cycloheximide has been researched along with Leukemia, Prolymphocytic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jansen, JH; Kluin-Nelemans, JC; Wientjens, GJ; Willemze, R | 1 |
| Evans, RL; Evans, SS; Han, T; Lee, DB; Tomasi, TB | 1 |
2 other study(ies) available for cycloheximide and Leukemia, Prolymphocytic
| Article | Year |
|---|---|
Production of tumor necrosis factor-alpha by normal and malignant B lymphocytes in response to interferon-alpha, interferon-gamma and interleukin-4.
Topics: B-Lymphocytes; Cycloheximide; Humans; Interferon-alpha; Interferon-gamma; Interleukin-4; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Prolymphocytic; Palatine Tonsil; Transcription, Genetic; Tumor Necrosis Factor-alpha | 1992 |
Monoclonal antibody to the interferon-inducible protein Leu-13 triggers aggregation and inhibits proliferation of leukemic B cells.
Topics: Antibodies, Monoclonal; Antigens, Differentiation; B-Lymphocytes; Cell Aggregation; Cell Division; Cells, Cultured; Cycloheximide; Dose-Response Relationship, Drug; Humans; Interferon Type I; Interleukin-4; Leukemia; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Prolymphocytic; Nucleosides; Up-Regulation | 1990 |